Comprehensive Multi-Omics Analysis of C4orf19 in Head and Neck Squamous Cell Carcinoma: Developing Prognostic Models for Predicting Responses to Immunotherapy and Chemotherapy - Takeaways - MDSpire

Comprehensive Multi-Omics Analysis of C4orf19 in Head and Neck Squamous Cell Carcinoma: Developing Prognostic Models for Predicting Responses to Immunotherapy and Chemotherapy

  • By

  • Da Huang

  • Yuxuan Guo

  • Mingfen Chen

  • Guoqun Chen

  • Guangchun He

  • Chanjuan Zheng

  • Shujun Fu

  • Jie Wang

  • Yian Wang

  • Xiyun Deng

  • January 30, 2026

  • 0 min

Share

  • 1

    Head and neck squamous cell carcinoma (HNSCC) is a prevalent malignancy with rising incidence and a current 5-year survival rate of approximately 60%.

  • 2

    C4orf19 is downregulated in HNSCC and its high expression correlates with favorable prognosis and enhanced sensitivity to chemotherapy.

  • 3

    Integrative analyses indicate that C4orf19 expression is associated with immune checkpoint molecules and tumor microenvironment composition.

  • 4

    C4orf19 has potential as a predictive biomarker for immunotherapy response, addressing the need for specific treatment selection in HNSCC.

  • 5

    The study utilized bioinformatics and clinical data to develop prognostic models integrating C4orf19 for predicting treatment outcomes in HNSCC patients.

Original Source(s)

Comprehensive Multi-Omics Analysis of C4orf19 in Head and Neck Squamous Cell Carcinoma: Developing Prognostic Models for Predicting Responses to Immunotherapy and Chemotherapy

  • by Da Huang, Yuxuan Guo, Mingfen Chen, Guoqun Chen, Guangchun He, Chanjuan Zheng, Shujun Fu, Jie Wang, Yian Wang, Xiyun Deng

  • January 30, 2026

Related Content

Real-world healthcare resource use and costs associated with the management of locally advanced head and neck cancer in Portugal – TRACE2 study

Editorial: Biomarkers in head and neck cancer: genomic insights and nuclear medicine innovations

Case Report: A seventy-year-stable chest wall bronchogenic cyst with sudden enlargement: coincidence or connection with a concurrent thymic carcinoma?